Harrow, Inc. Capital Units, Authorized
Harrow, Inc. (HROW) had Capital Units, Authorized of 95.00 million shares as of 2014-09-10, per its 10-K filed 2016-03-23.
Discontinued › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2016-03-23
- 2014-09-10: Capital Units, Authorized 95.00M shares.
- 2013-02-08: Capital Units, Authorized 95.00M shares.
- 2012-02-28: Capital Units, Authorized 400.00M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2014-09-10 | 95.00M shares 10-K · filed 2016-03-23 |
| 2013-02-08 | 95.00M shares 10-K · filed 2015-03-12 |
| 2012-02-28 | 400.00M shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |